AI Lung Cancer Screening: A groundbreaking AI-driven screening initiative in Goa detects lung cancer in early stages, flagging over 500 high-risk patients and uncovering 7 previously undiagnosed ...

A University of York spin out which aims to revolutionise lung cancer diagnosis has reported further commercial progress in the US.

Under a new commercialization agreement, Ease Healthcare will market the LEAP (Lung Enzyme Activity Profile) early detection test that incorporates HydroGraph’s patented fractal graphene.

TAIPEI, TAIWAN - Media OutReach Newswire - 16 August 2025 - Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Yet, progress is within reach. In Taiwan, thanks to the ...

VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced its role in a new ...

Hawkeye Bio is a clinical-stage biotechnology company developing low-cost diagnostic tests for early detection of cancer, neurodegenerative, and inflammatory diseases. Using a patented biosensor ...

The company aims to substantially reduce lung cancer mortality by offering a patient-safe, affordable solution to achieve population-scale lung cancer screening compliance for at-risk individuals.

Groundbreaking new cancer detection technique replaces radioactive tracers with diamond sensor University of Warwick scientists have created a device that is designed ...

AI cancer detection has been touted as being as good as or better than doctors — but now, it seems that it has atrophied doctors' brains.

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung cancer.